Details
Stereochemistry | UNKNOWN |
Molecular Formula | C18H26N2S.ClH |
Molecular Weight | 338.938 |
Optical Activity | ( - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN1C2=C(C=CC=C2)C3=C1C(C)(CCN(C)C)SCC3
InChI
InChIKey=FJJSKKBQSGDHQK-UHFFFAOYSA-N
InChI=1S/C18H26N2S.ClH/c1-5-20-16-9-7-6-8-14(16)15-10-13-21-18(2,17(15)20)11-12-19(3)4;/h6-9H,5,10-13H2,1-4H3;1H
Molecular Formula | C18H26N2S |
Molecular Weight | 302.477 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Tandamine was developed as a selective serotonin reuptake inhibitor for the treatment of depression. Tandamine participated in clinical trials in hospitalized depressed patients, where it showed that the well-tolerated drug could be of some benefit for retarded depressions. In addition, was found in human volunteers, that tandamine possessed significant anticholinergic activity, to reduce appetite and to produce sedation. However, this drug has never been marketed.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The effects of tandamine, a new potential antidepressant agent, on biogenic amine uptake mechanisms and related activities. | 1976 May 15 |
|
Effects of tandamine and pirandamine, new potential antidepressants, on the brain uptake of norepinephrine and 5-hydroxytryptamine and related activities. | 1976 May 5 |
|
Effects of tandamine and pirandamine, selective blockers of biogenic amine uptake mechanisms, on gastric acid secretion and ulcer formation in the rat. | 1977 Apr 15 |
|
Clinical pharmacological studies of tandamine, a potential antidepressive drug. | 1977 Mar 23 |
|
Effect of acute and chronic treatment of tandamine, a new heterocyclic antidepressant, on biogenic amine metabolism and related activities. | 1979 Sep |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/334686
was administered in doses from 75 to 200 mg to a group of 20 hospitalized depressed patients.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 04:17:48 GMT 2023
by
admin
on
Sat Dec 16 04:17:48 GMT 2023
|
Record UNII |
W7F3645Q8Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
60188-75-2
Created by
admin on Sat Dec 16 04:17:48 GMT 2023 , Edited by admin on Sat Dec 16 04:17:48 GMT 2023
|
PRIMARY | |||
|
W7F3645Q8Y
Created by
admin on Sat Dec 16 04:17:48 GMT 2023 , Edited by admin on Sat Dec 16 04:17:48 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
RACEMATE -> ENANTIOMER | |||
|
ENANTIOMER -> ENANTIOMER |
|